Lv4
760 积分 2024-02-17 加入
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy
2个月前
已完结
Overcoming Resistance in EGFR‐Mutant Cancers: A Comprehensive Review of Inhibitor Evolution and SAR‐Based Design
2个月前
已完结
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance
2个月前
已完结
From G12C To Pan-RAS: The Expanding Therapeutic Landscape of KRAS-Mutant NSCLC
2个月前
已关闭
Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti–PD-1 resistance in non–small cell lung cancer
2个月前
已完结
Hybrid nanovesicles enhance antitumor efficacy in KRAS-mutant non-small cell lung cancer
2个月前
已完结
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer
2个月前
已完结
SNAI2 as a Prognostic Biomarker Based on Cancer-Associated Fibroblasts in Patients With Lung Adenocarcinoma
2个月前
已完结
Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
2个月前
已完结
Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
2个月前
已完结
皖公网安备34019202002308
